The aim of this study is to find the potential miRNA expression signature capable of predicting survival time for cervical squamous cell carcinoma (CSCC) patients.The expression of 332 miRNAs was measured in 131 (Training cohort) and 130 (Validation cohort) patients with CSCC in the Cancer Genome Atlas (TCGA) data portal. The miRNA expression signature was identified by Cox Proportion Hazard regression model to the Training data set, and subsequently validated in an independent Validation set. Kaplan-Meier curves and the receiver operating characteristic analyses of 5 years were used to access the overall survival of miRNA signature. MiRNA signature-gene target analysis was performed, followed by the construction of the regulatory network. ...
Clinicopathological characteristics alone are not enough to predict the survival of patients with ce...
To reconstruct the ceRNA biological network of cervical squamous cell carcinoma and endocervical ade...
Cervical cancer is the third most common cancer among women worldwide, and the fourth leading cause ...
Clinicopathological characteristics alone are not enough to predict the survival of patients with ce...
Clinicopathological characteristics alone are not enough to predict the survival of patients with ce...
AimTo characterize the miRNA expression profile in head and neck squamous cell carcinoma (HNSSC) acc...
Clinicopathological characteristics alone are not enough to predict the survival of patients with ce...
<div><p>Cervical cancer remains the third most frequently diagnosed and fourth leading cause of canc...
Cervical cancer remains the third most frequently diagnosed and fourth leading cause of cancer death...
Qian Chen,1 Xiaoyun Zeng,2 Dongping Huang,2 Xiaoqiang Qiu2 1Department of Research, Affiliated Tumor...
Clinicopathological characteristics alone are not enough to predict the survival of patients with ce...
Objective. We identified differentially expressed microRNAs (DEMs) between esophageal carcinoma (ESC...
Clinicopathological characteristics alone are not enough to predict the survival of patients with ce...
Small cell carcinoma of the cervix (SCCC) is very rare, and due to the long time period required to ...
Given the high morbidity and the trend of younger individuals being affected observed in cervical ca...
Clinicopathological characteristics alone are not enough to predict the survival of patients with ce...
To reconstruct the ceRNA biological network of cervical squamous cell carcinoma and endocervical ade...
Cervical cancer is the third most common cancer among women worldwide, and the fourth leading cause ...
Clinicopathological characteristics alone are not enough to predict the survival of patients with ce...
Clinicopathological characteristics alone are not enough to predict the survival of patients with ce...
AimTo characterize the miRNA expression profile in head and neck squamous cell carcinoma (HNSSC) acc...
Clinicopathological characteristics alone are not enough to predict the survival of patients with ce...
<div><p>Cervical cancer remains the third most frequently diagnosed and fourth leading cause of canc...
Cervical cancer remains the third most frequently diagnosed and fourth leading cause of cancer death...
Qian Chen,1 Xiaoyun Zeng,2 Dongping Huang,2 Xiaoqiang Qiu2 1Department of Research, Affiliated Tumor...
Clinicopathological characteristics alone are not enough to predict the survival of patients with ce...
Objective. We identified differentially expressed microRNAs (DEMs) between esophageal carcinoma (ESC...
Clinicopathological characteristics alone are not enough to predict the survival of patients with ce...
Small cell carcinoma of the cervix (SCCC) is very rare, and due to the long time period required to ...
Given the high morbidity and the trend of younger individuals being affected observed in cervical ca...
Clinicopathological characteristics alone are not enough to predict the survival of patients with ce...
To reconstruct the ceRNA biological network of cervical squamous cell carcinoma and endocervical ade...
Cervical cancer is the third most common cancer among women worldwide, and the fourth leading cause ...